Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
Pan Q, de Ruiter PE, Metselaar HJ, Kwekkeboom J, de Jonge J, Tilanus HW, Janssen HL, van der Laan LJ.
Hepatology. 2012 Jun;55(6):1673-83. doi: 10.1002/hep.25562. Epub 2012 Apr 18.
Related citations
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.
Denniston MM, Klevens RM, McQuillan GM, Jiles RB.
Hepatology. 2012 Jun;55(6):1652-61. doi: 10.1002/hep.25556. Epub 2012 Apr 10.
Prioritizing treatment experienced patients with hepatitis C infection for treatment with telaprevir: a number needed to treat approach.
Rowe IA, Armstrong MJ, Houlihan DD.
Hepatology. 2012 May;55(5):1644-5. doi: 10.1002/hep.25553. No abstract available.
Effect of interleukin-28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with pegylated interferon alpha-2a/ribavirin.
Pearlman BL, Ehleben C.
Hepatology. 2012 May;55(5):1645. doi: 10.1002/hep.25552. No abstract available.
Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
Stibbe KJ, Verveer C, Francke J, Hansen BE, Zondervan PE, Kuipers EJ, de Knegt RJ, van Vuuren AJ.
Scand J Gastroenterol. 2011 Jul;46(7-8):962-72. Epub 2011 May 30.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on